Navigation Links
Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
Date:12/5/2007

SHANGHAI, China, Dec. 5 /PRNewswire/ -- Representatives from over 40 Shanghai area hospitals, more than double the expected attendance, took part in the first annual Cinpathogen Hematology Conference at Shanghai's Equatorial Hotel. The conference, hosted by Cinpathogen Inc. and chaired by Professor Lin Guowei, Director of the Shanghai Clinical Epidemiology Institute, covered current developments in clinical laboratory medicine and shared valuable findings from the Shanghai Health Study.

"The level of interest in the conference was far beyond what we expected," said Dr. Richard Irons, Laboratory Director and Cinpathogen CEO. "It demonstrates the growing demand for high-quality healthcare delivery and research in China."

The event included presentations by Western and Chinese hematologists and pathologists on recent developments and research findings in the field of clinical diagnosis, hematology, toxicology, and pathology. The research presented was the result of the Shanghai Health Study, a 5-year-long clinical study of Chinese patients with hematopoietic disease, led by Cinpathogen Inc. through its partnership with Fudan University and the extensive cooperation of leading hospitals in Shanghai. Cinpathogen's well-established research relationships have allowed company doctors and scientists to diagnose, collect and characterize over 2000 cases of hematopoietic and lymphoid disease over the last 4 years, resulting in a dozen peer-reviewed publications and one of the world's largest tissue banks dedicated to diseases of the blood and immune system.

Professor Ouyang Renrong, former chairman of both the Chinese Hematology Society and the Shanghai Hematology Society, applauded the accomplishment. "The Shanghai Health Study is one-of-its-kind in China and probably in the world. It is strong evidence of how science can make outstanding contributions to society through an integrated, big sampling approach. Had each hospital in Shanghai focused on its own interest and kept its own samples for its own use, we would have not gained this level of in-depth research findings or the extensiveness of the tissue bank."

Cinpathogen Inc. is a major partner in the Fudan-Cinpathogen Center for Clinical and Molecular Research in the Institute of Biomedical Sciences at Fudan University. Cinpathogen integrates Western and Chinese medical research systems by bringing together clinical operations, modern diagnostic laboratories and access to one of the largest tissue banks dedicated to diseases of the blood and immune systems to support diagnosis and conduct protocol-driven research on the etiology, pathogenesis and treatment of disease.

Cinpathogen reports and publications appear in many peer-reviewed scientific journals, including Leukemia Research, International Journal of Hematology, Proceedings of the American Association for Cancer Research, and Chinese Journal of Oncology.

If you'd like more information about this topic or Cinpathogen, please contact Dr Richard D. Irons at (303) 381-2543 or email him at contact@cinpathogen.com.

http://www.cinpathogen.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Cinpathogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
2. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
3. Doping technique brings nanomechanical devices into the semiconductor world
4. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
5. The Food Allergy & Anaphylaxis Network (FAAN) and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies
6. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
7. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
8. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
9. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
10. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
11. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/4/2016)... ... December 02, 2016 , ... ... and -operated small businesses in federally funded research and development is welcome news ... for optics and photonics . , As part of the National Defense Authorization ...
(Date:12/4/2016)... and CAMBRIDGE, Mass. and ... Dec. 4, 2016 SystemOne, a company ... software platforms for the developing world, and Daktari ... a reality with its portable and ultrasensitive immunoassay-based ... a development and license agreement to integrate Daktari,s ...
(Date:12/2/2016)... NORWALK, Conn. , Dec. 2, 2016  The ... research presentations from the MMRF CoMMpass Study SM —the ... and accelerating precision medicine in multiple myeloma—will be presented ... (ASH) Annual Meeting & Exposition in San ... are helping to optimize treatment strategies, as well as ...
Breaking Biology Technology:
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/17/2016)... it has just released a new white paper authored by Zettar that covers the ... transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a complicated endeavor ...
(Date:11/15/2016)... 15, 2016 Research and Markets has announced ... 2021" report to their offering. ... ... by 2021 from USD 6.21 Billion in 2016, growing at a ... of the bioinformatics market is driven by the growing demand for ...
Breaking Biology News(10 mins):